A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration
Clinical trial NCT06970665 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06970665
- Sponsor
- Astellas Pharma Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-08
- Primary completion
- 2027-06-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.